The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Palonosetron Market Research Report 2025
Synopsis
Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
The global Palonosetron market was valued at US$ 113 million in 2023 and is anticipated to reach US$ 147.6 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
Palonosetron is a medication used to prevent nausea and vomiting caused by chemotherapy and surgery. It belongs to a class of drugs called 5-HT3 receptor antagonists, which inhibit the action of serotonin, a chemical in the body that triggers nausea and vomiting. The increasing incidence of cancer worldwide is a major driver for the palonosetron market. As more and more patients undergo chemotherapy, there is a growing need to manage side effects such as nausea and vomiting. With growing awareness about cancer treatment, patients, caretakers, and healthcare providers are seeking better prevention and management of chemotherapy-induced side effects. This drives the demand for medications like palonosetron. Technological advancements in healthcare have led to better detection and treatment of cancer. This has resulted in increased adoption of chemotherapy, leading to a higher demand for medications like palonosetron. While palonosetron is effective, there are other medications available for managing chemotherapy-induced nausea and vomiting. Competition among different medications in the market can drive innovation, resulting in increased demand for palonosetron. Higher healthcare expenditure and accessibility to healthcare facilities in many regions further contribute to the growth of the palonosetron market.
This report aims to provide a comprehensive presentation of the global market for Palonosetron, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Palonosetron.
Report Scope
The Palonosetron market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Palonosetron market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Palonosetron manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Helsinn Therapeutics
Teva
Dr. Reddys Laboratories
Cipla
Pfizer
Sagent Pharmaceuticals
Fresenius Kabi
Qilu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Sichuan Hairong Pharmaceutical
Exela Pharma
Segment by Type
Injection 0.25 mg/5 mL
Injection 20 mcg/kg (max 1.5 mg)
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Palonosetron manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Palonosetron in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
The global Palonosetron market was valued at US$ 113 million in 2023 and is anticipated to reach US$ 147.6 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
Palonosetron is a medication used to prevent nausea and vomiting caused by chemotherapy and surgery. It belongs to a class of drugs called 5-HT3 receptor antagonists, which inhibit the action of serotonin, a chemical in the body that triggers nausea and vomiting. The increasing incidence of cancer worldwide is a major driver for the palonosetron market. As more and more patients undergo chemotherapy, there is a growing need to manage side effects such as nausea and vomiting. With growing awareness about cancer treatment, patients, caretakers, and healthcare providers are seeking better prevention and management of chemotherapy-induced side effects. This drives the demand for medications like palonosetron. Technological advancements in healthcare have led to better detection and treatment of cancer. This has resulted in increased adoption of chemotherapy, leading to a higher demand for medications like palonosetron. While palonosetron is effective, there are other medications available for managing chemotherapy-induced nausea and vomiting. Competition among different medications in the market can drive innovation, resulting in increased demand for palonosetron. Higher healthcare expenditure and accessibility to healthcare facilities in many regions further contribute to the growth of the palonosetron market.
This report aims to provide a comprehensive presentation of the global market for Palonosetron, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Palonosetron.
Report Scope
The Palonosetron market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Palonosetron market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Palonosetron manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Helsinn Therapeutics
Teva
Dr. Reddys Laboratories
Cipla
Pfizer
Sagent Pharmaceuticals
Fresenius Kabi
Qilu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Sichuan Hairong Pharmaceutical
Exela Pharma
Segment by Type
Injection 0.25 mg/5 mL
Injection 20 mcg/kg (max 1.5 mg)
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Palonosetron manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Palonosetron in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Palonosetron Market Overview
1.1 Product Overview and Scope of Palonosetron
1.2 Palonosetron Segment by Type
1.2.1 Global Palonosetron Market Value Comparison by Type (2024-2030)
1.2.2 Injection 0.25 mg/5 mL
1.2.3 Injection 20 mcg/kg (max 1.5 mg)
1.3 Palonosetron Segment by Application
1.3.1 Global Palonosetron Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Palonosetron Market Size Estimates and Forecasts
1.4.1 Global Palonosetron Revenue 2019-2030
1.4.2 Global Palonosetron Sales 2019-2030
1.4.3 Global Palonosetron Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Palonosetron Market Competition by Manufacturers
2.1 Global Palonosetron Sales Market Share by Manufacturers (2019-2024)
2.2 Global Palonosetron Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Palonosetron Average Price by Manufacturers (2019-2024)
2.4 Global Palonosetron Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Palonosetron, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Palonosetron, Product Type & Application
2.7 Palonosetron Market Competitive Situation and Trends
2.7.1 Palonosetron Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Palonosetron Players Market Share by Revenue
2.7.3 Global Palonosetron Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Palonosetron Retrospective Market Scenario by Region
3.1 Global Palonosetron Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Palonosetron Global Palonosetron Sales by Region: 2019-2030
3.2.1 Global Palonosetron Sales by Region: 2019-2024
3.2.2 Global Palonosetron Sales by Region: 2025-2030
3.3 Global Palonosetron Global Palonosetron Revenue by Region: 2019-2030
3.3.1 Global Palonosetron Revenue by Region: 2019-2024
3.3.2 Global Palonosetron Revenue by Region: 2025-2030
3.4 North America Palonosetron Market Facts & Figures by Country
3.4.1 North America Palonosetron Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Palonosetron Sales by Country (2019-2030)
3.4.3 North America Palonosetron Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Palonosetron Market Facts & Figures by Country
3.5.1 Europe Palonosetron Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Palonosetron Sales by Country (2019-2030)
3.5.3 Europe Palonosetron Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Palonosetron Market Facts & Figures by Country
3.6.1 Asia Pacific Palonosetron Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Palonosetron Sales by Country (2019-2030)
3.6.3 Asia Pacific Palonosetron Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Palonosetron Market Facts & Figures by Country
3.7.1 Latin America Palonosetron Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Palonosetron Sales by Country (2019-2030)
3.7.3 Latin America Palonosetron Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Palonosetron Market Facts & Figures by Country
3.8.1 Middle East and Africa Palonosetron Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Palonosetron Sales by Country (2019-2030)
3.8.3 Middle East and Africa Palonosetron Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Palonosetron Sales by Type (2019-2030)
4.1.1 Global Palonosetron Sales by Type (2019-2024)
4.1.2 Global Palonosetron Sales by Type (2025-2030)
4.1.3 Global Palonosetron Sales Market Share by Type (2019-2030)
4.2 Global Palonosetron Revenue by Type (2019-2030)
4.2.1 Global Palonosetron Revenue by Type (2019-2024)
4.2.2 Global Palonosetron Revenue by Type (2025-2030)
4.2.3 Global Palonosetron Revenue Market Share by Type (2019-2030)
4.3 Global Palonosetron Price by Type (2019-2030)
5 Segment by Application
5.1 Global Palonosetron Sales by Application (2019-2030)
5.1.1 Global Palonosetron Sales by Application (2019-2024)
5.1.2 Global Palonosetron Sales by Application (2025-2030)
5.1.3 Global Palonosetron Sales Market Share by Application (2019-2030)
5.2 Global Palonosetron Revenue by Application (2019-2030)
5.2.1 Global Palonosetron Revenue by Application (2019-2024)
5.2.2 Global Palonosetron Revenue by Application (2025-2030)
5.2.3 Global Palonosetron Revenue Market Share by Application (2019-2030)
5.3 Global Palonosetron Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Helsinn Therapeutics
6.1.1 Helsinn Therapeutics Corporation Information
6.1.2 Helsinn Therapeutics Description and Business Overview
6.1.3 Helsinn Therapeutics Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Helsinn Therapeutics Palonosetron Product Portfolio
6.1.5 Helsinn Therapeutics Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Palonosetron Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Dr. Reddys Laboratories
6.3.1 Dr. Reddys Laboratories Corporation Information
6.3.2 Dr. Reddys Laboratories Description and Business Overview
6.3.3 Dr. Reddys Laboratories Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddys Laboratories Palonosetron Product Portfolio
6.3.5 Dr. Reddys Laboratories Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Palonosetron Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Palonosetron Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Sagent Pharmaceuticals
6.6.1 Sagent Pharmaceuticals Corporation Information
6.6.2 Sagent Pharmaceuticals Description and Business Overview
6.6.3 Sagent Pharmaceuticals Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sagent Pharmaceuticals Palonosetron Product Portfolio
6.6.5 Sagent Pharmaceuticals Recent Developments/Updates
6.7 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Kabi Palonosetron Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Corporation Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qilu Pharmaceutical Palonosetron Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Jiangsu Aosaikang Pharmaceutical
6.9.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
6.9.2 Jiangsu Aosaikang Pharmaceutical Description and Business Overview
6.9.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolio
6.9.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
6.10 Sichuan Hairong Pharmaceutical
6.10.1 Sichuan Hairong Pharmaceutical Corporation Information
6.10.2 Sichuan Hairong Pharmaceutical Description and Business Overview
6.10.3 Sichuan Hairong Pharmaceutical Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sichuan Hairong Pharmaceutical Palonosetron Product Portfolio
6.10.5 Sichuan Hairong Pharmaceutical Recent Developments/Updates
6.11 Exela Pharma
6.11.1 Exela Pharma Corporation Information
6.11.2 Exela Pharma Palonosetron Description and Business Overview
6.11.3 Exela Pharma Palonosetron Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Exela Pharma Palonosetron Product Portfolio
6.11.5 Exela Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Palonosetron Industry Chain Analysis
7.2 Palonosetron Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Palonosetron Production Mode & Process
7.4 Palonosetron Sales and Marketing
7.4.1 Palonosetron Sales Channels
7.4.2 Palonosetron Distributors
7.5 Palonosetron Customers
8 Palonosetron Market Dynamics
8.1 Palonosetron Industry Trends
8.2 Palonosetron Market Drivers
8.3 Palonosetron Market Challenges
8.4 Palonosetron Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Palonosetron Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Palonosetron Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Palonosetron Market Competitive Situation by Manufacturers in 2023
Table 4. Global Palonosetron Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Palonosetron Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Palonosetron Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Palonosetron Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Palonosetron Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Palonosetron, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Palonosetron, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Palonosetron, Product Type & Application
Table 12. Global Key Manufacturers of Palonosetron, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Palonosetron by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Palonosetron as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Palonosetron Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Palonosetron Sales by Region (2019-2024) & (K Units)
Table 18. Global Palonosetron Sales Market Share by Region (2019-2024)
Table 19. Global Palonosetron Sales by Region (2025-2030) & (K Units)
Table 20. Global Palonosetron Sales Market Share by Region (2025-2030)
Table 21. Global Palonosetron Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Palonosetron Revenue Market Share by Region (2019-2024)
Table 23. Global Palonosetron Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Palonosetron Revenue Market Share by Region (2025-2030)
Table 25. North America Palonosetron Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Palonosetron Sales by Country (2019-2024) & (K Units)
Table 27. North America Palonosetron Sales by Country (2025-2030) & (K Units)
Table 28. North America Palonosetron Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Palonosetron Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Palonosetron Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Palonosetron Sales by Country (2019-2024) & (K Units)
Table 32. Europe Palonosetron Sales by Country (2025-2030) & (K Units)
Table 33. Europe Palonosetron Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Palonosetron Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Palonosetron Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Palonosetron Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Palonosetron Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Palonosetron Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Palonosetron Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Palonosetron Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Palonosetron Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Palonosetron Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Palonosetron Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Palonosetron Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Palonosetron Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Palonosetron Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Palonosetron Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Palonosetron Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Palonosetron Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Palonosetron Sales (K Units) by Type (2019-2024)
Table 51. Global Palonosetron Sales (K Units) by Type (2025-2030)
Table 52. Global Palonosetron Sales Market Share by Type (2019-2024)
Table 53. Global Palonosetron Sales Market Share by Type (2025-2030)
Table 54. Global Palonosetron Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Palonosetron Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Palonosetron Revenue Market Share by Type (2019-2024)
Table 57. Global Palonosetron Revenue Market Share by Type (2025-2030)
Table 58. Global Palonosetron Price (USD/Unit) by Type (2019-2024)
Table 59. Global Palonosetron Price (USD/Unit) by Type (2025-2030)
Table 60. Global Palonosetron Sales (K Units) by Application (2019-2024)
Table 61. Global Palonosetron Sales (K Units) by Application (2025-2030)
Table 62. Global Palonosetron Sales Market Share by Application (2019-2024)
Table 63. Global Palonosetron Sales Market Share by Application (2025-2030)
Table 64. Global Palonosetron Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Palonosetron Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Palonosetron Revenue Market Share by Application (2019-2024)
Table 67. Global Palonosetron Revenue Market Share by Application (2025-2030)
Table 68. Global Palonosetron Price (USD/Unit) by Application (2019-2024)
Table 69. Global Palonosetron Price (USD/Unit) by Application (2025-2030)
Table 70. Helsinn Therapeutics Corporation Information
Table 71. Helsinn Therapeutics Description and Business Overview
Table 72. Helsinn Therapeutics Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Helsinn Therapeutics Palonosetron Product
Table 74. Helsinn Therapeutics Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Teva Palonosetron Product
Table 79. Teva Recent Developments/Updates
Table 80. Dr. Reddys Laboratories Corporation Information
Table 81. Dr. Reddys Laboratories Description and Business Overview
Table 82. Dr. Reddys Laboratories Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Dr. Reddys Laboratories Palonosetron Product
Table 84. Dr. Reddys Laboratories Recent Developments/Updates
Table 85. Cipla Corporation Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Cipla Palonosetron Product
Table 89. Cipla Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Palonosetron Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Sagent Pharmaceuticals Corporation Information
Table 96. Sagent Pharmaceuticals Description and Business Overview
Table 97. Sagent Pharmaceuticals Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Sagent Pharmaceuticals Palonosetron Product
Table 99. Sagent Pharmaceuticals Recent Developments/Updates
Table 100. Fresenius Kabi Corporation Information
Table 101. Fresenius Kabi Description and Business Overview
Table 102. Fresenius Kabi Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Fresenius Kabi Palonosetron Product
Table 104. Fresenius Kabi Recent Developments/Updates
Table 105. Qilu Pharmaceutical Corporation Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Qilu Pharmaceutical Palonosetron Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 111. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 112. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Jiangsu Aosaikang Pharmaceutical Palonosetron Product
Table 114. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 115. Sichuan Hairong Pharmaceutical Corporation Information
Table 116. Sichuan Hairong Pharmaceutical Description and Business Overview
Table 117. Sichuan Hairong Pharmaceutical Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Sichuan Hairong Pharmaceutical Palonosetron Product
Table 119. Sichuan Hairong Pharmaceutical Recent Developments/Updates
Table 120. Exela Pharma Corporation Information
Table 121. Exela Pharma Description and Business Overview
Table 122. Exela Pharma Palonosetron Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Exela Pharma Palonosetron Product
Table 124. Exela Pharma Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Palonosetron Distributors List
Table 128. Palonosetron Customers List
Table 129. Palonosetron Market Trends
Table 130. Palonosetron Market Drivers
Table 131. Palonosetron Market Challenges
Table 132. Palonosetron Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Palonosetron
Figure 2. Global Palonosetron Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Palonosetron Market Share by Type in 2023 & 2030
Figure 4. Injection 0.25 mg/5 mL Product Picture
Figure 5. Injection 20 mcg/kg (max 1.5 mg) Product Picture
Figure 6. Global Palonosetron Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Palonosetron Market Share by Application in 2023 & 2030
Figure 8. Adults
Figure 9. Children
Figure 10. Global Palonosetron Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Palonosetron Market Size (2019-2030) & (US$ Million)
Figure 12. Global Palonosetron Sales (2019-2030) & (K Units)
Figure 13. Global Palonosetron Average Price (USD/Unit) & (2019-2030)
Figure 14. Palonosetron Report Years Considered
Figure 15. Palonosetron Sales Share by Manufacturers in 2023
Figure 16. Global Palonosetron Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Palonosetron Players: Market Share by Revenue in 2023
Figure 18. Palonosetron Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Palonosetron Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Palonosetron Sales Market Share by Country (2019-2030)
Figure 21. North America Palonosetron Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Palonosetron Sales Market Share by Country (2019-2030)
Figure 25. Europe Palonosetron Revenue Market Share by Country (2019-2030)
Figure 26. Germany Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Palonosetron Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Palonosetron Revenue Market Share by Region (2019-2030)
Figure 33. China Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Palonosetron Sales Market Share by Country (2019-2030)
Figure 44. Latin America Palonosetron Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Palonosetron Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Palonosetron Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Palonosetron Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Palonosetron by Type (2019-2030)
Figure 54. Global Revenue Market Share of Palonosetron by Type (2019-2030)
Figure 55. Global Palonosetron Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Palonosetron by Application (2019-2030)
Figure 57. Global Revenue Market Share of Palonosetron by Application (2019-2030)
Figure 58. Global Palonosetron Price (USD/Unit) by Application (2019-2030)
Figure 59. Palonosetron Value Chain
Figure 60. Palonosetron Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
